BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8666931)

  • 1. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
    Doolan DL; Sedegah M; Hedstrom RC; Hobart P; Charoenvit Y; Hoffman SL
    J Exp Med; 1996 Apr; 183(4):1739-46. PubMed ID: 8666931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
    Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
    Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.
    Sacci JB; Hollingdale MR; Sedegah M
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28475711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
    Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
    Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
    Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
    Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
    Sedegah M; Hedstrom R; Hobart P; Hoffman SL
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9866-70. PubMed ID: 7937907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological responses of neonates and infants to DNA vaccines.
    Sedegah M; Hoffman SL
    Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine.
    Hoffman SL; Sedegah M; Hedstrom RC
    Vaccine; 1994 Dec; 12(16):1529-33. PubMed ID: 7879419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.
    Bruna-Romero O; Rocha CD; Tsuji M; Gazzinelli RT
    Vaccine; 2004 Sep; 22(27-28):3575-84. PubMed ID: 15315836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
    Wang HH; Rogers WO; Kang YH; Sedegah M; Hoffman SL
    Mol Biochem Parasitol; 1995 Feb; 69(2):139-48. PubMed ID: 7770079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient induction of protective anti-malaria immunity by recombinant adenovirus.
    Rodrigues EG; Zavala F; Nussenzweig RS; Wilson JM; Tsuji M
    Vaccine; 1998 Nov; 16(19):1812-7. PubMed ID: 9795385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo.
    Huang J; Li X; Kohno K; Hatano M; Tokuhisa T; Murray PJ; Brocker T; Tsuji M
    J Immunol Methods; 2013 Jan; 387(1-2):254-61. PubMed ID: 23142461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.